Diadema Partners »

Dianthus Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $839k 10k 83.92

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Wellington Management Company
Fairmount Funds Management
Avidity Partners Management
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
T. Rowe Price Associates
Polar Capital Holdings

View all funds holding Dianthus Therapeutics